Who has invested in BiOligo?

The Carlyle Group, CICC Capital, BioVenture are named among the investors backing BiOligo.

BiOligo Funding: $41M Raised, Series A (2021)

BiOligo funding overview

BiOligo has raised $41M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2021. The round record for BiOligo runs through 2021; nothing later has been disclosed. Investors on record include The Carlyle Group, CICC Capital, BioVenture. 3 distinct backers are named across the disclosed rounds.

BiOligo at a glance

Total raised: $41M
Latest round: Series A
Latest round date: October 2021
Notable investors: The Carlyle Group, CICC Capital, BioVenture

Frequently asked about BiOligo funding

How much has BiOligo raised?: BiOligo has raised $41M in total disclosed funding across the rounds on record.
Who has invested in BiOligo?: The Carlyle Group, CICC Capital, BioVenture are named among the investors backing BiOligo.
What was the latest BiOligo funding round?: The most recent disclosed round is a Series A, announced in October 2021.
Where is BiOligo based?: No headquarters location is disclosed for BiOligo.
When did BiOligo last raise?: The last disclosed BiOligo round closed in October 2021 at Series A.

Round data for BiOligo is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

BiOligo Funding: $41M Raised, Series A (2021)

BiOligo funding overview

BiOligo at a glance

Frequently asked about BiOligo funding

Companies related to BiOligo (15)

Browse related funding lists (4)